ADK and myeloid sarcoma: Although the activity status of proteins involved in the termination of ADO signaling (ENTs and the cytoplasmic enzymes such as adenosine kinase) is not known in MS, it is reasonable to state that excess ADO signaling through extracellular ADO accumulation drives inflammation and MS progression.